AFA
0.35
4900%
MTL
0.001
-50%
VBS
0.17
129.7%
NVA
0.83
-42.4%
TAS
0.033
106.3%
VML
0.24
-34.2%
AAJ
0.029
81.3%
C7A
0.004
-33.3%
LMG
0.043
65.4%
MKR
0.062
-33.3%
MCM
0.215
65.4%
PKO
0.004
-33.3%
VHM
0.74
60.9%
TMX
0.004
-33.3%
WYX
0.07
59.1%
RML
0.08
-30.4%
GSS
0.365
52.1%
LRD
0.028
-30%
EVG
0.038
52%
SER
0.007
-30%
MSG
0.012
50%
HMI
0.039
-29.1%
ROG
0.006
50%
YUG
0.044
-29%
UNT
0.013
44.4%
ENT
0.005
-28.6%
ELT
0.36
41.2%
MRQ
0.005
-28.6%
ZAG
0.031
40.9%
RNX
0.005
-28.6%
EMU
0.045
40.6%
SRJ
0.016
-27.3%
WBE
0.007
40%
AVM
0.095
-26.9%
SKK
0.065
38.3%
BKT
0.019
-26.9%
CMG
0.22
37.5%
ADG
0.011
-26.7%
EDE
0.042
35.5%
IFG
0.011
-26.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

LBT Innovations (ASX: LBT): Completes first sale of APAS® PharmaQC

Australian medical technology company LBT Innovations (ASX: LBT) has completed its first sale of APAS® PharmaQC to Thermo Fisher Scientific (Thermo Fisher), aiming to provide efficiencies and improve traceability within environmental monitoring workflows using AI | ASX announcement: https://announcements.asx.com.au/asxpdf/20240222/pdf/060pf49b9csjfg.pdf